Key Takeaways Casgevy, CRSP's first marketed therapy, treats SCD and TDT but saw just $10 million in 2024 sales. The therapy's complex, multi-step process has slowed adoption despite its curative potential. Casgevy faces pressure from cheaper approved drugs and emerging gene-editing competitors.CRISPR Therapeutics’ (CRSP) first marketed product is the one-shot gene therapy Casgevy, approved in late 2023 and early 2024 across the United States and Europe for two blood disorder indications — sickle cell dis ...

核心观点 - 公司受益于有机增长和战略收购 持续提升业绩表现 是公用事业板块的稳健投资选择 [1] - 2025年每股收益预计达5.71美元 同比增长5.9% 营收预计48.5亿美元 同比增长3.6% [2][8] - 长期(3-5年)盈利增长率7.4% 过去四个季度平均盈利超预期0.8% [2] 财务表现 - 总债务与资本比率为56.05% 优于行业平均59.23% 一季度利息保障倍数3.6倍 显示偿债能力良好 [3] - 净资产收益率10.35% 高于行业平均9.98% 反映资本使用效率优于同业 [4] - 年度股息每股3.31美元 股息收益率2.35% 超过标普500平均1.24% 长期股息增长率预计7-9% [5] 业务扩张 - 2024年完成13笔收购 新增69,500客户 截至2025年4月30日有18笔待完成收购 预计再增37,400客户 [6][8] - 专注于服务5,000-50,000客户规模的公用事业公司收购 通过无机和有机方式持续扩大业务 [7] 市场表现 - 年内股价回报13.4% 远超行业6.3%的涨幅 [9] 同业比较 - Artesian Resources(ARTNA)2025年EPS预计同比增长9.1% 过去四季平均盈利超预期18.6% [12] - California Water Service(CWT)长期盈利增长率8.78% 过去四季平均盈利超预期57.9% [12] - NiSource(NI)长期盈利增长率7.88% 2025年EPS预计同比增长7.4% [12]

Meta Platforms (NASDAQ: META) is scheduled to distribute its quarterly dividend on June 26. The social media stock has demonstrated strong performance throughout 2025, driven by investor optimism around Meta’s bold push into artificial intelligence infrastructure and its expansion into new advertising channels.META closed Wednesday’s session at $695.77, representing a 16% gain year-to-date and a 0.46% increase over the past week. The performance positions Meta among the top performers in the technology sect ...

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of investors (the “Class”) who purchased or acquired the securities of Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) between May 2, 2024 and May 6, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain ...

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) between February 25, 2025 and May 7, 2025, inclusive. For more information, submit a form at Krispy Kreme, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or c ...

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District of Oregon on behalf of investors (the “Class”) who purchased or acquired the securities of Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officer ...

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, inclusive. For more information, submit a form at Rocket Pharmaceuticals, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@ber ...

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of investors (the “Class”) who purchased or acquired the securities of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Compan ...

Our approach has earned us 500+ five-star reviews from satisfied members who are already seeing the benefits. Don’t miss out—join now and start maximizing your returns!We invest thousands of hours and over $100,000 annually into researching the most profitable investment opportunities—all to bring you real estate strategies at just a fraction of the cost.There's nothing better than REITs ( VNQ ), in my opinion, if your goal is to earn high passive income and retire early.He is the leader of the investing gr ...

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Eastern District of Virginia on behalf of investors who purchased or acquired the securities of MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) between April 30, 2024 and April 4, 2025, inclusive., alleging violations of the Securities Exchange Act of 1934 against the C ...